Genelux Corp GNLX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/02/24 EDT
3.48quote price arrow up+0.20 (+6.10%)
Volume
116,285
52 week range
3.06 - 40.98
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.48
  • 52 Week High40.98
  • 52 Week High Date06/22/23
  • 52 Week Low3.06
  • 52 Week Low Date04/30/24

Key Stats

  • Market Cap93.492M
  • Shares Out26.87M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-75.16

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.48
  • 52 Week High40.98
  • 52 Week High Date06/22/23
  • 52 Week Low3.06
  • 52 Week Low Date04/30/24
  • Market Cap93.492M
  • Shares Out26.87M
  • 10 Day Average Volume0.14M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-75.16

RATIOS/PROFITABILITY

  • EPS (TTM)-1.22
  • P/E (TTM)-2.86
  • Fwd P/E (NTM)-3.72
  • EBITDA (TTM)-23.666M
  • ROE (TTM)-
  • Revenue (TTM)170,000.002
  • Gross Margin (TTM)-
  • Net Margin (TTM)-16,645.29%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genelux Corp

 

Content From Our Affiliates

Profile

MORE
Genelux Corporation is a late clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its clinical and preclinical product candidates are intended to selectively kill tumor cells and induce a robust immune response against a patient’s tumor neoantigens. Its product candidate, Olvi-Vec (olvimulogene...
Thomas Zindrick J.D.
Chairman of the Board, President, Chief Executive Officer
Lourie Zak
Chief Financial Officer
Sean Ryder J.D.
General Counsel, Corporate Secretary
Joseph Cappello Ph.D.
Vice President of Pharmaceutical Development, General Manager of Manufacturing
Tony Yu Ph.D.
Vice President - Clinical Trial Operations
Address
2625 Townsgate Road, Suite 230
Westlake Village, CA
91361
United States

Top Peers

SYMBOLLASTCHG%CHG
ALVR
Allovir Inc
0.8065-0.0035-0.4321%
ELTX
Elicio Therapeutics Inc
9.00+0.15+1.69%
ALLK
Allakos Inc
1.10-0.03-2.65%
PMVP
PMV Pharmaceuticals Inc
1.87+0.01+0.54%
IOBT
IO Biotech Inc
1.53-0.02-1.29%